Alethea has uncovered a new wave of coordinated, AI-driven inauthentic accounts directly targeting pharmaceutical companies with narrative attacks that portray them as profiteering, careless, or politically compromised. This activity builds on the more than 400 accounts Alethea previously documented that use a technique we call ‘PromtPasta’.
New findings signal a troubling evolution: pharmaceutical brands have now landed directly in the crosshairs of adversarial operators abusing LLMs to shape online discourse inauthentically.
For pharmaceutical and healthcare companies, the risks are especially acute: pricing debates, policy scrutiny, and brand reputation can all be distorted in real time by coordinated AI-driven campaigns. The tactics employed may also lead to manipulation of platform algorithms, potentially increasing the visibility of negative narratives about your brand.